Literature DB >> 2115157

Risk factors for Pseudomonas aeruginosa colonization in cystic fibrosis patients.

E Kerem1, M Corey, R Stein, R Gold, H Levison.   

Abstract

In an attempt to study the association between Pseudomonas aeruginosa colonization and clinical factors present before colonization, we studied 502 patients who attended our cystic fibrosis (CF) clinic between 1975 and 1988 and who were not colonized with P. aeruginosa before the study period. Twelve percent of the patients became colonized with P. aeruginosa before the age of 1 year and 44% by the age of 7 years. In a birth cohort followed from diagnosis during the study period, 23% were colonized with P. aeruginosa before age 1 year and 67% before age 7 years. Early P. aeruginosa colonization was associated with early diagnosis of CF. Presence of meconium ileus, gastrointestinal symptoms and pancreatic insufficiency at the time of diagnosis was also associated with early colonization. There was no association between the presence of respiratory symptoms at the time of diagnosis and age at first P. aeruginosa colonization. In families in which more than one sibling had CF, the age of P. aeruginosa acquisition was similar in the first colonized and the subsequently colonized siblings. In the year before the colonization patients with P. aeruginosa who were older than 1 year had higher rates of hospitalization and spent more days in hospital compared with patients without P. aeruginosa. In conclusion most P. aeruginosa colonization occurs at a younger age than previously reported. Early age at diagnosis and presence of CF-associated gastrointestinal abnormalities increase the likelihood of earlier colonization of P. aeruginosa.

Entities:  

Mesh:

Year:  1990        PMID: 2115157     DOI: 10.1097/00006454-199007000-00008

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  13 in total

1.  Twenty-five-year outbreak of Pseudomonas aeruginosa infecting individuals with cystic fibrosis: identification of the prairie epidemic strain.

Authors:  Michael D Parkins; Bryan A Glezerson; Christopher D Sibley; Kristen A Sibley; Jessica Duong; Swathi Purighalla; Christopher H Mody; Matthew L Workentine; Douglas G Storey; Michael G Surette; Harvey R Rabin
Journal:  J Clin Microbiol       Date:  2014-01-22       Impact factor: 5.948

2.  Pseudomonas aeruginosa in children with cystic fibrosis diagnosed through newborn screening: assessment of clinic exposures and microbial genotypes.

Authors:  Don Hayes; Susan E West; Michael J Rock; Zhanhai Li; Mark L Splaingard; Philip M Farrell
Journal:  Pediatr Pulmonol       Date:  2010-07

3.  Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort.

Authors:  Margaret Rosenfeld; Julia Emerson; Sharon McNamara; Valeria Thompson; Bonnie W Ramsey; Wayne Morgan; Ronald L Gibson
Journal:  J Cyst Fibros       Date:  2012-05-01       Impact factor: 5.482

Review 4.  Targeting Persistent Biofilm Infections: Reconsidering the Topography of the Infection Site during Model Selection.

Authors:  Ilana Kolodkin-Gal; Malena Cohen-Cymberknoh; Gideon Zamir; Igor Tsesis; Eyal Rosen
Journal:  Microorganisms       Date:  2022-06-06

5.  The age at onset of chronic Pseudomonas aeruginosa colonization in cystic fibrosis--prognostic significance.

Authors:  C Aebi; R Bracher; S Liechti-Gallati; H Tschäppeler; A Rüdeberg; R Kraemer
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

6.  Predictors of mucoid Pseudomonas colonization in cystic fibrosis patients.

Authors:  Hara Levy; Leslie A Kalish; Carolyn L Cannon; K Christopher García; Craig Gerard; Don Goldmann; Gerald B Pier; Scott T Weiss; A A Colin
Journal:  Pediatr Pulmonol       Date:  2008-05

Review 7.  Cystic fibrosis related diabetes.

Authors:  Donal O'Shea; Jean O'Connell
Journal:  Curr Diab Rep       Date:  2014-08       Impact factor: 4.810

Review 8.  Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.

Authors:  Simon C Langton Hewer; Alan R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2017-04-25

9.  Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response.

Authors:  John C Lam; Ranjani Somayaji; Michael G Surette; Harvey R Rabin; Michael D Parkins
Journal:  BMC Infect Dis       Date:  2015-03-22       Impact factor: 3.090

10.  Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry.

Authors:  Réchana Vongthilath; Bénédicte Richaud Thiriez; Clémence Dehillotte; Lydie Lemonnier; Alicia Guillien; Bruno Degano; Marie-Laure Dalphin; Jean-Charles Dalphin; Patrick Plésiat
Journal:  PLoS One       Date:  2019-01-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.